References
- van Marwijk Kooy, M, van Prooijen, HC, Moes, M, et al. Use of leukocyte-depleted platelet concentrates for the prevention of refractoriness and primary HLA alloimmunisation: a prospective, randomized trial. Blood 1991; 77: 201–205
- Murphy, MF, Metcalfe, P, Thomas, H, et al. Use of leukocyte-poor blood components and HLA-matched platelet donors to prevent HLA alloimmunization. Br J Haematology 1986; 62: 529–534
- Bishop, JF, McGrath, K, Wolf, MM, et al. Clinical factors influencing the efficacy of pooled platelet transfusions. Blood 1988; 71: 383–387
- Rio, B, Andreu, G, Nicod, A, et al. Thrombocytopenia in venocclusive disease of the liver after bone marrow transplantation or chemotherapy. Blood 1986; 67: 1773–1776
- Moroff, R, Garratty, G, Heal, JM, et al. Selection of platelets for refractory patients by HLA-matching and prospective cross-matching. Transfusion 1992; 32: 633–640
- Bolgiano DC, Larson EB, Slichter SJ. A model to determine required pool size for HLA-typed community donor apheresis programmes. Transfusion 1989; 29: 306–310
- Bishop, JF, Matthews, JP, Yuen, K, et al. The definition of refractoriness to platelet transfusions. Transfusion Medicine 1992; 2: 35–41
- Lown JAG, Ivey JG. Evaluation of a solid phase red cell adherence technique for platelet antibody testing. Transfusion Medicine 1991; 1: 163–167
- Nordhagen R, Flaathen ST. Chloroquine removal of HLA antigens from platelets for the platelet immunofluorescence test. Vox Sanguinis 1985; 48: 156–159
- Kurata, Y, Oshida, M, Take, H, et al. New approach to eliminate HLA class I antigens from platelet surface without cell damage: treatment at pH 3.0. Vox Sanguinis 1989; 57: 199–204
- Shanwell, A, Sallender, S, Olsson, I, et al. An alloimmunized, thrombocytopenic patient successfully transfused with acid-treated, random-donor platelets. Br J Haematology 1991; 79: 462–465
- Murphy, MF, Brozovic, B, Murphy, W, et al. British committee for standards in haematology, working party of the blood transfusion task force. Guidelines for platelet transfusions. Transfusion Medicine 1992; 2: 311–318
- Freedman, J, Gafni, A, Garvey, MB, et al. A cost effectiveness evaluation of platelet crossmatching and HLA-matching in the management of alloimmunized thrombocytopenic patients. Transfusion 1989; 29: 201–207
- O'Connell, BA, Lee, EJ, Rothko, K, et al. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood 1992; 79: 527–531